Daegu, South Korea

Su Young Oh

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kyungpook National University Industry-Academic Cooperation Foundation. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Su Young Oh. Retrieved from https://idiyas.com/inventor/su-young-oh-dqbu7p7m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Su Young Oh: Innovator in Cancer Treatment

Introduction

Su Young Oh is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development.

Latest Patents

Su Young Oh holds a patent for a pharmaceutical composition comprising MicroRNA-30B, MicroRNA-133A, or MicroRNA-202-5P inhibitors for inhibiting cancer. This anticancer composition is designed to suppress the proliferation of cancer cells, making it a promising candidate for cancer treatment.

Career Highlights

Su Young Oh is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. His work focuses on developing effective treatments that target specific microRNAs involved in cancer progression.

Collaborations

He collaborates with You-Mie Lee, who is also involved in research related to cancer treatment. Their partnership enhances the potential for innovative solutions in the medical field.

Conclusion

Su Young Oh's contributions to cancer treatment through his patented pharmaceutical composition highlight the importance of innovation in medical research. His work continues to pave the way for advancements in cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…